CELLSCRIPT™ provides products and technologies for making and using RNA for translation in cells for clinical research and therapeutics, including RNA comprising pseudouridine (Ψ) and other modified nucleosides covered by patents licensed from the University of Pennsylvania. Products include enzymes and kits for in vitro transcription, co-transcriptional or post-transcriptional 5’ RNA capping and 3’ RNA polyadenylation. Experienced modified mRNA production service provider for preclinical and early stage clinical trials for select clients.